| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Avelumab in paediatric patients with refractory or relapsed solid tumours: dose-escalation results from an open-label, single-arm, phase 1/2 trial
|
Loeb, David M.
|
|
|
71 |
10 |
p. 2485-2495
|
artikel
|
| 2 |
Cellular and soluble immune checkpoint signaling forms PD-L1 and PD-1 in renal tumor tissue and in blood
|
Keber, Corinna U.
|
|
|
71 |
10 |
p. 2381-2389
|
artikel
|
| 3 |
CMTM6 as a master regulator of PD-L1
|
Yaseen, Mahmoud Mohammad
|
|
|
71 |
10 |
p. 2325-2340
|
artikel
|
| 4 |
Comprehensive analyses of prognostic biomarkers and immune infiltrates among histone lysine demethylases (KDMs) in hepatocellular carcinoma
|
Qu, Li-Hua
|
|
|
71 |
10 |
p. 2449-2467
|
artikel
|
| 5 |
Correction to: Functional virus‑specific memory T cells survey glioblastoma
|
Ning, Jianfang
|
|
|
71 |
10 |
p. 2577-2579
|
artikel
|
| 6 |
Correction to: Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden
|
Femel, Julia
|
|
|
71 |
10 |
p. 2581
|
artikel
|
| 7 |
Elotuzumab, a potential therapeutic humanized anti-SLAMF7 monoclonal antibody, enhances natural killer cell-mediated killing of primary effusion lymphoma cells
|
Panaampon, Jutatip
|
|
|
71 |
10 |
p. 2497-2509
|
artikel
|
| 8 |
Engineering T-cells with chimeric antigen receptors to combat hematological cancers: an update on clinical trials
|
Ormhøj, Maria
|
|
|
71 |
10 |
p. 2301-2311
|
artikel
|
| 9 |
Enhancement of CD70-specific CAR T treatment by IFN-γ released from oHSV-1-infected glioblastoma
|
Zhu, Guidong
|
|
|
71 |
10 |
p. 2433-2448
|
artikel
|
| 10 |
Fc-independent functions of anti-CTLA-4 antibodies contribute to anti-tumor efficacy
|
Sato, Yosuke
|
|
|
71 |
10 |
p. 2421-2431
|
artikel
|
| 11 |
Immune epitopes identification and designing of a multi-epitope vaccine against bovine leukemia virus: a molecular dynamics and immune simulation approaches
|
Samad, Abdus
|
|
|
71 |
10 |
p. 2535-2548
|
artikel
|
| 12 |
Immunosuppressive properties of human PD-1 + , PDL-1 + and CD80 + dendritic cells from lymph nodes aspirates of lung cancer patients
|
Kwiecień, Iwona
|
|
|
71 |
10 |
p. 2469-2483
|
artikel
|
| 13 |
Immunosuppressive TREM2(+) macrophages are associated with undesirable prognosis and responses to anti-PD-1 immunotherapy in non-small cell lung cancer
|
Zhang, Hongyu
|
|
|
71 |
10 |
p. 2511-2522
|
artikel
|
| 14 |
Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on B cell marker genes to predict prognosis and immunotherapy response in lung adenocarcinoma
|
Song, Peng
|
|
|
71 |
10 |
p. 2341-2354
|
artikel
|
| 15 |
Murine fecal microbiota transfer models selectively colonize human microbes and reveal transcriptional programs associated with response to neoadjuvant checkpoint inhibitors
|
Shaikh, Fyza Y.
|
|
|
71 |
10 |
p. 2405-2420
|
artikel
|
| 16 |
Parvimonas micra is associated with tumour immune profiles in molecular subtypes of colorectal cancer
|
Löwenmark, Thyra
|
|
|
71 |
10 |
p. 2565-2575
|
artikel
|
| 17 |
Penpulimab, an anti-PD1 IgG1 antibody in the treatment of advanced or metastatic upper gastrointestinal cancers
|
Zheng, Yulong
|
|
|
71 |
10 |
p. 2371-2379
|
artikel
|
| 18 |
Targeting PD-L1 and TIGIT could restore intratumoral CD8 T cell function in human colorectal cancer
|
Thibaudin, Marion
|
|
|
71 |
10 |
p. 2549-2563
|
artikel
|
| 19 |
The nuclear transportation of PD-L1 and the function in tumor immunity and progression
|
Qu, Liyan
|
|
|
71 |
10 |
p. 2313-2323
|
artikel
|
| 20 |
Transient 40 °C-shock potentiates cytotoxic responses of Vδ2+ γδ T cell via HSP70 upregulation
|
Lin, Li
|
|
|
71 |
10 |
p. 2391-2404
|
artikel
|
| 21 |
Tumour cell-activated platelets modulate the immunological activity of CD4+, CD8+, and NK cells, which is efficiently antagonized by heparin
|
Gockel, Lukas M.
|
|
|
71 |
10 |
p. 2523-2533
|
artikel
|
| 22 |
VSSP abrogates murine ovarian tumor-associated myeloid cell-driven immune suppression and induces M1 polarization in tumor-associated macrophages from ovarian cancer patients
|
Khan, ANM Nazmul H.
|
|
|
71 |
10 |
p. 2355-2369
|
artikel
|
Tijdschrift beschrijving